A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2002
11/21/2002	WO2002092014A2 Destruction of prions using vibriolysin or variants thereof
11/21/2002	WO2002092013A2 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/21/2002	WO2002092008A2 Use of il-18 inhibitors for the treatement or prevention of sepsis
11/21/2002	WO2002091995A2 Method to induce neovascular formation and tissue regeneration
11/21/2002	WO2002074981A3 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase
11/21/2002	WO2002074907A3 Methods of modulating surfactant production
11/21/2002	WO2002072798A9 Fas ligand-expressing hematopoietic cells for transplantation
11/21/2002	WO2002069896A3 Connexin enhances chemotherapy-induced apoptosis in human cancer cells inhibiting tumor cell proliferation
11/21/2002	WO2002066068A3 Method of treating neurological diseases
11/21/2002	WO2002059604A8 Diagnosis and treatment of multiple sclerosis
11/21/2002	WO2002055098A3 Latency associated peptide for providing latency to pharmaceutically active proteins
11/21/2002	WO2002046402A3 Regulation of human patched-like protein
11/21/2002	WO2002042468A3 Glycosyltransferase vectors for treating cancer
11/21/2002	WO2002031201A3 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products
11/21/2002	WO2002018637A3 Diagnosis and treatment of prostate cancer
11/21/2002	WO2002000730A3 Pd-l2 molecules: novel pd-1 ligands and uses therefor
11/21/2002	WO2001094383A3 Mutated furin polypeptides having improved characteristics
11/21/2002	WO2001087350A3 Treatment of human papillomavirus (hpv)-infected cells
11/21/2002	WO2001034646A9 Recombinant gelatins
11/21/2002	WO2001025465A9 Adeno-associated viruses and uses thereof
11/21/2002	WO2001025462A9 Production of recombinant aav using adenovirus comprising aav rep/cap genes
11/21/2002	WO2001019397A9 Methods and compositions utilizing rad51
11/21/2002	US20020174448 Transgenic expression from a SOCS-3 promoter in vertebrate cells
11/21/2002	US20020174446 Identification of genes involved in alzheimer's disease using drosophila melanogaster
11/21/2002	US20020173642 Human gastric cancer antigen gene and gastric cancer antigen protein
11/21/2002	US20020173641 Nucleotide sequences coding polypeptides for use in human therapeutics, pharmacology and diagnostics
11/21/2002	US20020173638 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer
11/21/2002	US20020173624 Polypeptide for use in treatment and prevention of liver, nervous system and glandular disorders
11/21/2002	US20020173479 Administering genes to suppress cancer
11/21/2002	US20020173478 Controlling, prevention gene expression
11/21/2002	US20020173477 Antiallergens
11/21/2002	US20020173476 Cancer diagnosis
11/21/2002	US20020173461 Methods for enhancing the efficacy of cancer therapy
11/21/2002	US20020173458 Polypeptides; genetic engineering
11/21/2002	US20020173457 Polypeptides
11/21/2002	US20020173039 Packaging systems for human recombinant adenovirus to be used in gene therapy
11/21/2002	US20020173030 Lenitiviral packaging system for use as tool in genetic engineering
11/21/2002	US20020173006 Generating chimeric zinc finger protein; obtain nucleotide sequences coding chimeric protein, transform cells, express nucleotide sequences, recover protein
11/21/2002	US20020172999 Novel KIAA1061-like cell adhesion molecule-like proteins and polynucleotides encoding them
11/21/2002	US20020172994 Nucleotide sequences coding polypeptides for use in the treatment of inflammation, tumors, arthritis, asthma, viral and inflammatory bowel diseases
11/21/2002	US20020172959 Compositions and methods relating to lung specific genes and proteins
11/21/2002	US20020172958 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries
11/21/2002	US20020172957 Nucleotide squences coding preferential polypepttide for use in the diagnosis, prevention, treatment and classification of lung cancer
11/21/2002	US20020172941 Inducing immune response against feline immunodeficiency virus; obtain animal, administer protective agent, detect immunological response against viral infection
11/21/2002	US20020172690 Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
11/21/2002	US20020172683 Used for therapy of viral pathologies, such as those due to HIV-1 or HIV-2 infections, for screening compounds
11/21/2002	US20020172678 For regulating cellular proliferation and chemotaxis
11/21/2002	US20020172673 Method for down-regulating IgE
11/21/2002	US20020172671 CAIP-like gene family
11/21/2002	US20020172664 Methods of treating Parkinson's disease using recombinant adeno-associated virus virions
11/21/2002	US20020172663 Localized myocardial injection method for treating ischemic myocardium
11/21/2002	US20020172659 Methods and materials for treating inflammatory diseases
11/21/2002	CA2460603A1 Unigene unidirectional antisense library
11/21/2002	CA2447564A1 Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
11/21/2002	CA2447548A1 Complexes for transferring substances of interest into a cell
11/21/2002	CA2447518A1 Therapeutic use of rank antagonists
11/21/2002	CA2447444A1 Antisense permeation enhancers
11/21/2002	CA2447343A1 Method to induce neovascular formation and tissue regeneration
11/21/2002	CA2447286A1 Random gene unidirectional antisense library
11/21/2002	CA2447116A1 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/21/2002	CA2447052A1 Combined approach to treatment of cancer using a c-myc antisense oligomer
11/21/2002	CA2447050A1 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002	CA2447004A1 Antisense modulation of ptp1b expression
11/21/2002	CA2446991A1 Agents that regulate apoptosis
11/21/2002	CA2446806A1 Anti-cd26 monoclonal antibodies as therapy for diseases associated with cells expressing cd26
11/21/2002	CA2446582A1 Reagents and methods for modulating dkk-mediated interactions
11/21/2002	CA2446127A1 Destruction of prions using vibriolysin or variants thereof
11/21/2002	CA2446075A1 Novel maxizyme
11/21/2002	CA2443964A1 Use of osteopontin for the treatment and/or prevention of neurologic diseases
11/21/2002	CA2443627A1 Genes expressed in breast cancer as prognostic and therapeutic targets
11/21/2002	CA2443160A1 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof
11/21/2002	CA2429718A1 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
11/20/2002	EP1258494A1 Multiprotein complexes from eukaryotes
11/20/2002	EP1258493A1 Cleavage and polyadenylation complex of precursor mRNA
11/20/2002	EP1258492A1 N-substituted oligomers and methods for their synthesis, e.g. polyglycine bearing nucleic acid bases
11/20/2002	EP1257827A1 Diagnosis of breast cancer using bcmp-11 as marker
11/20/2002	EP1257669A1 Antisense modulation of e2f transcription factor 3 expression
11/20/2002	EP1257658A1 Method for increasing the gene expression of transfected genes
11/20/2002	EP1257657A2 Autoregulatory expression vector for gene therapy
11/20/2002	EP1257651A2 Nucleic acids of the human abc1 gene and applications thereof
11/20/2002	EP1257642A1 Partners of ptb1 domain of fe65, preparation and uses
11/20/2002	EP1257641A2 Method of modulating glycosylation pathways
11/20/2002	EP1257639A2 Nucleozymes with endonuclease activity
11/20/2002	EP1257637A2 Sphingosine kinases
11/20/2002	EP1257633A1 Presenilin deficient multipotent cell lines and screening methods for intramembrane regulated proteolytic activities using these lines
11/20/2002	EP1257583A2 METHODS FOR THE PREVENTION AND TREATMENT OF INFECTIONS USING ANTI-C3b(i) ANTIBODIES
11/20/2002	EP1257581A1 Compounds related to or derived from gfr alpha 4 and their use
11/20/2002	EP1257579A2 Novel human g protein coupled receptor proteins and polynucleotides encoding the same
11/20/2002	EP1257560A1 Bcl-2-like polynucleotides, polypeptides, and antibodies
11/20/2002	EP1257298A1 Cosmid dna constructs and methods of making and using the same
11/20/2002	EP1257292A1 Use of il-18 inhibitors
11/20/2002	EP1257291A1 Novel antibody with specificity for colon cancer
11/20/2002	EP1257289A1 Immunotherapy using interleukin 13 receptor subunit alpha 2
11/20/2002	EP1257287A1 Compositions and methods for the early diagnosis of ovarian cancer
11/20/2002	EP1257286A2 Cancer treatment and prognosis involving hes-1 protein
11/20/2002	EP1257285A2 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer
11/20/2002	EP1257282A1 Pancreatic stem cells and their use in transplantation
11/20/2002	EP0946189B1 Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
11/20/2002	EP0758394B1 Bifunctional protein, preparation and use
11/20/2002	EP0711127B1 Methods of preparing gas-filled liposomes

1 ... 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 ... 870